This compound is primarily used in the synthesis of chiral intermediates for pharmaceuticals, particularly in the production of drugs that require specific stereochemistry for efficacy. It serves as a key building block in the creation of active pharmaceutical ingredients (APIs) for treatments targeting metabolic disorders, infections, and other diseases. Additionally, it is employed in organic chemistry research to develop novel compounds with potential therapeutic applications. Its benzyl ester group enhances stability and facilitates selective reactions in multi-step synthetic processes.